Compagnie Lombard Odier SCmA’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-1
Closed -$1K – 720
2016
Q4
$1K Hold
1
– – ﹤0.01% 796
2016
Q3
$1K Hold
1
– – ﹤0.01% 891
2016
Q2
$2K Hold
1
– – ﹤0.01% 880
2016
Q1
$2K Hold
1
– – ﹤0.01% 945
2015
Q4
$3K Buy
+1
New +$4.23K ﹤0.01% 905

Other funds holding ACHV

Compagnie Lombard Odier SCmA's ACHV Position: Q1 2017 in Review

Compagnie Lombard Odier SCmA sold out of Achieve Life Sciences (ACHV) in Q1 2017, closing a stake of 1 share — an estimated $1K sold.

Compagnie Lombard Odier SCmA first reported a position in ACHV in Q4 2015 and held it in 5 quarters. The position peaked at $3K in Q4 2015. 26 funds tracked by Wall St. Rank hold ACHV as of Q1 2017.

  • Compagnie Lombard Odier SCmA reported no remaining Achieve Life Sciences position as of Q1 2017 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 1 Achieve Life Sciences share in Q1 2017, an estimated $1K.
  • Compagnie Lombard Odier SCmA first reported a position in Achieve Life Sciences in Q4 2015 and held it in 5 quarters.
  • Compagnie Lombard Odier SCmA's Achieve Life Sciences position peaked at $3K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2017, filed 15 May 2017.